BREAKING
Home » Archive by Category "Drugs and antibiotics" (Page 2)

Vyleesi receives FDA nod to treat women with low sexual desire

By

The U.S. Food and Drug Administration today approved Vyleesi (bremelanotide) to treat acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women. “There are women who, for...

Victoza receives FDA nod for treating pediatric patients with type 2 diabetes

By

The U.S. Food and Drug Administration today approved Victoza (liraglutide) injection for treatment of pediatric patients 10 years or older with type 2 diabetes. Victoza is the first non-insulin drug approved...

Antibiotic, Zerbaxa, receives FDA approval for treating hospital-acquired pneumonia

By

The U.S. Food and Drug Administration today approved a new indication for the previously FDA-approved drug, Zerbaxa (ceftolozane and tazobactam) for the treatment of hospital-acquired bacterial pneumonia...

Antibiotics prescribed by dentists unnecessary eight out of 10 times: Study

By

Antibiotics prescribed by dentists as a preemptive strike against infection are unnecessary 81% of the time, according to a study published today in JAMA Network Open. The findings are important because...

Amikacin Sulfate and Prochlorperazine Edisylate recalled due to sterility issues

By

East Brunswick, New Jersey company, Heritage Pharmaceuticals Inc. announced the recall of Amikacin Sulfate Injection, USP, 1g/4 mL (250mg/mL), Lot: VEAC025, Expiry Date: October 2019 and Prochlorperazine...

Nipah virus: Ebola antiviral, Remdesivir, effective against infection in monkeys

By

The experimental antiviral drug remdesivir completely protected four African green monkeys from a lethal dose of Nipah virus, according to a new study in Science Translational Medicine from National...

Anticoagulant, Fragmin, receives FDA approval for pediatric use

By

The U.S. Food and Drug Administration today approved Fragmin (dalteparin sodium) injection, for subcutaneous use, to reduce the recurrence of symptomatic venous thromboembolism (VTE) in pediatric patients...

Huntington’s disease: New drug successfully lowers levels of the abnormal protein

By

An international clinical trial has found that a new drug for Huntington’s disease is safe, and that treatment with the drug successfully lowers levels of the abnormal protein that causes the debilitating...

Malaria: Tafenoquine approved for prophylaxis and treatment

By

Travelers to many parts of the world are at risk for contracting malaria, According to the Centers for Disease Control and Prevention (CDC), approximately 1,700 cases occur each year among international...

Hepatitis C drug, Mavyret, approved to treat children

By

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) tablets to treat all six genotypes of hepatitis C virus (HCV) in children ages 12 to 17. Mavyret was previously...